BLZE three-lens brief
Evidence-based stock research on BLZE. Three independent lenses — Foundation, Expansion, Climate — examine live data from SEC filings, the Federal Reserve, and market feeds. Every claim traces to its primary source.
Performance
Price down 6.95% in the last session — a material single-day move. · Trading >3% below the 50-day MA — short-term weakness.
- Price down 6.95% in the last session — a material single-day move.
- Trading >3% below the 50-day MA — short-term weakness.
- Currently unprofitable on a trailing basis — no P/E multiple available.
- Analyst mean target $22.83 — 85% above current (6 analysts).
BLZE closed at $12.31 (-6.95%) as of 2026-09-11. Market cap: $761.99M. Price is below the 50-day MA and above the 200-day MA. Positives: analyst mean target $22.83 — 85% above current (6 analysts).. Concerns: price down 6.95% in the last session — a material single-day move.; trading >3% below the 50-day MA — short-term weakness.. Last quarter: Revenue $42.71M, net income -$5.09M, free cash flow $33.52M.
Why three lenses on BLZE, not one.
A single reasoning model has blind spots it doesn’t know about. We examine BLZEacross Foundation (fundamentals), Expansion (growth runway and market expansion), and Climate (macro/sector). Disagreement between lenses is surfaced, not hidden — it’s how you know when HOLD is the honest call.
Read the full methodologyDrop it in your newsletter or blog.
Free to embed. Updates every 6 hours. Links back to the full brief.
<iframe src="https://clearpathinvest.app/embed/BLZE" width="100%" height="420" frameborder="0" loading="lazy" title="ClearPath BLZE brief"></iframe>